Works matching IS 15391604 AND DT 2024 AND VI 23 AND IP 1

Results: 9

Group sequential design with maximin efficiency robust test for immunotherapy with generalized delayed treatment effect.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 107, doi. 10.1002/pst.2341
By:
- Li, Bosheng;
- Zhang, Jingyi;
- Yang, Wenyun;
- Su, Liwen;
- Yan, Fangrong
Publication type:
Article
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 91, doi. 10.1002/pst.2340
By:
- Weber, Hans‐Jochen;
- Corson, Stephen;
- Li, Jiang;
- Mercier, François;
- Roychoudhury, Satrajit;
- Sailer, Martin Oliver;
- Sun, Steven;
- Todd, Alexander;
- Yung, Godwin
Publication type:
Article
A conservative approach to leveraging external evidence for effective clinical trial design.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 81, doi. 10.1002/pst.2339
By:
- Rigat, Fabio
Publication type:
Article
A marginalized two‐part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancers.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 60, doi. 10.1002/pst.2338
By:
- Rustand, Denis;
- Briollais, Laurent;
- Rondeau, Virginie
Publication type:
Article
Sample size calculation in clinical trials with two co‐primary endpoints including overdispersed count and continuous outcomes.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 46, doi. 10.1002/pst.2337
By:
- Homma, Gosuke;
- Yoshida, Takuma
Publication type:
Article
Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 31, doi. 10.1002/pst.2336
By:
- Wang, Guanbo;
- Poulin‐Costello, Melanie;
- Pang, Herbert;
- Zhu, Jiawen;
- Helms, Hans‐Joachim;
- Reyes‐Rivera, Irmarie;
- Platt, Robert W.;
- Pang, Menglan;
- Koukounari, Artemis
Publication type:
Article
Interim decision making in seamless trial designs: An application in an adaptive dose‐finding study in a rare kidney disease.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 20, doi. 10.1002/pst.2335
By:
- Papachristofi, Olympia;
- Bornkamp, Björn;
- Wright, Melanie;
- Friede, Tim
Publication type:
Article
Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one‐arm and hybrid control two‐arm trials.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 4, doi. 10.1002/pst.2334
By:
- Kopp‐Schneider, Annette;
- Wiesenfarth, Manuel;
- Held, Leonhard;
- Calderazzo, Silvia
Publication type:
Article
Issue Information.
Published in:
Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 1, doi. 10.1002/pst.2307
Publication type:
Article